Practices

Cases Investigated

Beasley Allen is currently investigating the following cases involving medical devices and drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Missouri court denies J&J request to delay talc-related cancer trials

January 5, 2017 - The Missouri Court of Appeals has denied a request by Johnson & Johnson to delay upcoming trials of ovarian cancer claims brought by individuals and families who allege that use of the... Read More


Lawyers for Talc Cancer Victims Say ‘Judicial Hellhole’ Label Ignores Science

December 15, 2016 - Lawyers representing women whose ovarian cancers have been tied to the use of body powders containing talc say that efforts by corporate-funded defense lawyers to label Missouri courts as... Read More


Ethicon’s Physiomesh used in hernia repair linked to complications, higher incidence of surgical recurrence

December 9, 2016 - Intended for hernia repair, Physiomesh is a flexible polypropylene mesh designed to reinforce the abdominal wall, preventing future hernias from occurring. Read More


Beasley Allen appointed to leadership role in Johnson & Johnson talc MDL

December 6, 2016 - Leigh O’Dell, Beasley Allen Principal, will serve as Co-Lead Counsel for multidistrict litigation (MDL) involving the Johnson & Johnson talc litigation consolidated in Trenton, N.J. Read More


Johnson & Johnson, DePuy Orthopaedics hit with $1 billion verdict in third hip implant bellwether trial

December 1, 2016 - Texas jurors deliberated for less than a day before returning a verdict finding Johnson & Johnson’s DePuy Orthopaedics Inc. unit liable for injuries related to its Pinnacle metal-on-metal... Read More




Jury finds Johnson & Johnson, Imerys liable for $70 million in third ovarian cancer talc trial

October 27, 2016 - A third St. Louis jury has found Johnson & Johnson liable for ovarian cancer linked to talcum powder in its Johnson’s Baby Powder and Shower to Shower products. Talc supplier Imerys also... Read More


Diabetes drug Invokana linked to ketoacidosis

September 30, 2016 - Invokana, which contains the drug ingredient canagliflozin, was approved by the Food and Drug Administration (FDA) in March 2012. Read More


New Jersey Court ruling in talc hearing ignores internal documents

September 6, 2016 - Ruling to strike expert witnesses in New Jersey litigation ignores J&J admission that talc products carry ovarian cancer risk. Read More


back to top